encyclopedia of medical concepts
ψ
ψ
ψ
ψ
Lipid A
More information
in Books
or on
Definition
: Lipid A is the biologically active component of lipopolysaccharides. It shows strong endotoxic activity and exhibits immunogenic properties.
Other names
A, Lipid
Substance
CAS Registry & name
Categories
Source
Drugs
*
ASO4 mixture
0
*Aluminum Hydroxide
Lipid A/*analogs & derivatives.
Hum Vaccin 2008 Jul-Aug;4(4):262-70
hepatitis B vaccine AS04
0
*Hepatitis B Vaccines
Lipid A/*analogs & derivatives.
Kidney Int 2008 Apr;73(7):856-62
ASO2A adjuvant
0
*Saponins
Drug Combinations
Lipid A/*analogs & derivatives
Adjuvants, Immunologic.
Vaccine 2005 Apr 8;23(20):2591-601
RC529
0
Lipid A/*analogs & derivatives.
J Endotoxin Res 2002;8(6);453-8
RC524
0
Lipid A/*analogs & derivatives.
J Endotoxin Res 2002;8(6);453-8
adjuvant SBAS-
2
0
*Saponins
Lipid A/*analogs & derivatives
Adjuvants, Immunologic.
Eur J Cancer 2003 Jan;39(1):70-7
SBAS4 adjuvant system
0
*Alum Compounds
*Lipid A
Adjuvants, Immunologic
Hepatitis B Vaccines.
Vaccine 2000 Apr 14;18(20):2095-101
E5564
0
Lipid A/*analogs & derivatives
Lipopolysaccharides/antagonists & inhibitors.
J Chromatogr B Biomed Sci Appl 1999 Dec 24;736(1-2):67-75
OM 174 lipid
0
*Lipopolysaccharides
Lipid A.
B 1287
0
*Lipopolysaccharides
Lipid A/antagonists & inhibitors.
J Immunol 1998 Nov 15;161(10):5413-20
B 975
0
Lipid A/*analogs & derivatives.
Infect Immun 1998 Jun;66(6):2562-9
detox adjuvant
0
*Cytoskeletal Proteins
Drug Combinations
Lipid A/*analogs & derivatives.
Pharma Action
Adjuvants, Immunologic
Clin Cancer Res 1998 Mar;4(3):619-27
DY 9973
0
Lipid A/*analogs & derivatives.
Immunopharmacol Immunotoxicol 1996 Nov;18(4):477-95
JTP 3309
0
Lipid A/*analogs & derivatives.
Kakkaku 1995 Apr;70(4):285-92
1-
O-
(5-
(carboxy)pentanoyl)-
2-
deoxy-
2-
(2,2-
difluorotetradecanamido)-
3-
O-
(3-
(tetradecanoyloxy)tetradecanoyl)-
4-
O-
phosphonoglucopyranose
0
Lipid A/*analogs & derivatives.
Biosci Biotechnol Biochem 1995 Mar;59(3):501-6
E 5531
0
Lipid A/*analogs & derivatives.
Science 1995 Apr 7;268(5207):80-3
N-
(2,4,6-
trinitrophenyl-
6-
aminocaproyl)-
4'-
monophosphoryl lipid A
0
*Trinitrobenzenes
Lipid A/*analogs & derivatives.
Infect Immun 1995 Jan;63(1):168-74
A 603
0
Lipid A/*analogs & derivatives.
Int J Immunopharmacol 1994 Aug;16(8):659-65
A 602
0
Lipid A/*analogs & derivatives.
Int J Immunopharmacol 1994 Aug;16(8):659-65
A 601
50696-27-0 Hydrazinecarboximidamide, 2-
((5-
hydroxy-
2-
pyridinyl)methylene)
Lipid A/*analogs & derivatives.
Int J Immunopharmacol 1994 Aug;16(8):659-65
SDZ 280-
961
147376-46-3 Tetradecanoic acid, 3-
((1-
oxotetradecyl)oxy)-
, 4-
carboxy-
2-
((3-
hydroxy-
1-
oxotetradecyl)amino)butyl ester, (2S-
(1(S*),2R*(S*)))
Lipid A/*analogs & derivatives
Signal Transduction.
J Immunol 1994 Dec 1;153(11):5230-8
lauroyl-
lipid IVA
0
*Glycoproteins
Lipid A/*analogs & derivatives.
J Bacteriol 1994 Nov;176(22):6944-51
3-
deoxy-
2-
octulosonic acid(2)-
lipid IV(A)
143600-83-3
Lipid A/*analogs & derivatives.
J Bacteriol 1994 Aug;176(15):4646-55
B 464
0
Lipid A/*analogs & derivatives.
Surgery 1994 Aug;116(2):339-47
ONO 4007
0
Lipid A/*analogs & derivatives.
Cancer Immunol Immunother 1994 May;38(5):287-93
2-
deoxy-
2-
(2-
fluoro-
3-
hydroxytetradecanamido)-
3-
O-
(3-
hydroxytetradecanoyl)-
4-
O-
phosphonoglucopyranose
146452-52-0
Lipid A/*analogs & derivatives
Pyrrolidonecarboxylic Acid/*analogs & derivatives.
Biosci Biotechnol Biochem 1993 Sep;57(9):1526-9
A 113
149118-02-5 D-
Galactose, 2-
deoxy-
2-
((1-
oxo-
3-
((1-
oxotetradecyl)oxy)tetradecyl)amino)-
, 4-
(dihydrogen phosphate) 3-
(3-
((1-
oxotetradecyl)oxy)tetradecanoate), (2(R),3(R))
Lipid A/*analogs & derivatives.
Biol Pharm Bull 1993 Feb;16(2):201-2
A 103
96345-59-4 D-
Glucose, 2-
deoxy-
2-
((1-
oxo-
3-
((1-
oxotetradecyl)oxy)tetradecyl)amino)-
, 4-
(dihydrogen phosphate) 3-
(3-
((1-
oxotetradecyl)oxy)tetradecanoate), (2(R),3(R))
Lipid A/*analogs & derivatives.
Biol Pharm Bull 1993 Feb;16(2):201-2
SDZ 281-
288
143060-83-7
Lipid A/*analogs & derivatives.
Infect Immun 1993 May;61(5):2015-23
SDZ 880-
431
101662-30-0
Lipid A/*analogs & derivatives.
Infect Immun 1993 May;61(5):2015-23
succinyl lipid A
0
Lipid A/*analogs & derivatives.
J Gen Microbiol 1992 Dec;138 (Pt 12):2503-8
6'-
O-
(6-
aminocaproyl)-
4'-
O-
monophosphoryl lipid A
144710-90-7
Lipid A/*analogs & derivatives.
Bioconjug Chem 1992 Nov-Dec;3(6):540-8
DT 5461
123598-19-6 Pentanedioic acid, 3-
((2-
deoxy-
6-
O-
(2-
deoxy-
3-
O-
(((1-
oxododecyl)amino)acetyl)-
2-
((1-
oxotetradecyl)amino)-
4-
O-
phosphono-
beta-
D-
glucopyranosyl)-
3-
O-
(((1-
oxododecyl)amino)acetyl)-
2-
((1-
oxotetradecyl)amino)-
alpha-
D-
glucopyranosyl)oxy)
*Disaccharides
Lipid A/*analogs & derivatives.
Cancer Immunol Immunother 1992;35(5):307-14
Ribi adjuvant
0
*Cord Factors
*Cell Wall Skeleton
Lipid A/*analogs & derivatives
Adjuvants, Immunologic.
J Immunol Methods 1992 Jul 31;152(1):105-13
A 503
134404-00-5
Lipid A/*analogs & derivatives.
Int J Immunopharmacol 1992 Feb;14(2):221-6
6-
O-
(2-
deoxy-
3-
O-
(3-
hydroxytetradecanoyl)-
2-
((3-
hydroxytetradecanoyl)amino)-
glycopyranosyl)-
2-
deoxy-
3-
O-
(3-
hydroxytetradecanoyl)-
2-
((3-
hydroxytetradecanoyl)amino)-
glucopyranosylphosphonate
131061-35-3
*Organophosphorus Compounds
Lipid A/*analogs & derivatives.
J Med Chem 1992 May 29;35(11):2070-4
2-
deoxy-
2-
((3R)-
3-
hydroxytetradecanamido)-
3-
O-
((3-
tetradecanoyloxy)tetradecanoyl)glucopyranosyl fluoride 4-
(dihydrogen phosphate)
138527-40-9
Lipid A/*analogs & derivatives.
Carbohydr Res 1991 Dec 30;222:83-97
2,6-
dideoxy-
6-
fluoro-
2-
(3-
hydroxytetradecanamido)-
3-
O-
((3-
tetradecanoyloxy)tetradecanoyl)glucopyranose 4-
(dihydrogen phosphate)
138527-42-1
Lipid A/*analogs & derivatives.
Carbohydr Res 1991 Dec 30;222:83-97
2-
deoxy-
2-
((2,2-
difluoro-
3-
hydroxytetradecanoyl)amino)-
3-
O-
(3-
(tetradecanoyloxy)tetradecanoyl)glucopyranose 4-
phosphate
132760-29-3
Lipid A/*analogs & derivatives.
J Med Chem 1991;34(8):2643
SDZ MRL 953
123136-61-8 alpha-
D-
Glucopyranose, 2-
deoxy-
2-
((3-
hydroxy-
1-
oxotetradecyl)amino)-
, 1-
(dihydrogen phosphate) 3,4-
bis(3-
hydroxytetradecanoate), (2(R),3(R),4(R))
Lipid A/*analogs & derivatives.
Antimicrob Agents Chemother 1991;35(3):500
GLA 60
111247-04-2 D-
Glucose, 2-
deoxy-
2-
((3-
hydroxy-
1-
oxotetradecyl)amino)-
, 4-
(dihydrogen phosphate) 3-
(3-
((1-
oxotetradecyl)oxy)tetradecanoate), (2(R),3(R))
Lipid A/*analogs & derivatives.
Pharma Action
Adjuvants, Immunologic
;
Antiviral Agents
Antiviral Res 1988;9(1-2):37
GLA 40
99777-22-7
Lipid A/*analogs & derivatives.
Eur J Immunol 1987;17(5):663
preparation 516
0
Lipid A/*analogs & derivatives.
Eur J Biochem 1986;160(1):55
diphosphoryl lipid A
0
Lipid A/*analogs & derivatives.
Radiat Res 1986;107(1):107
GLA 27
89756-57-0
Lipid A/*analogs & derivatives
Tumor Necrosis Factor-alpha.
J Biochem (Tokyo) 1986;99(5):1377
monophosphoryl lipid A
0
Lipid A/*analogs & derivatives.
Pharma Action
Adjuvants, Immunologic
Infect Immun 1986;52(1):6
lipid X
86559-73-1
*Glycolipids
Escherichia coli
Lipid A
Macrophage Activation.
Proc Natl Acad Sci USA 1985;82(2):282
lipid Y
88090-57-7
*Glycolipids
Lipid A
Macrophage Activation.
Proc Natl Acad Sci USA 1985;82(2):282
lipid A precursors, bacterial
0
*Glycolipids
Lipid A/*analogs & derivatives
Salmonella typhimurium.
J Immunol 1984;132(1):347
2-
amino-
6-
O-
(2-
amino-
2-
deoxy-
glucopyranosyl)-
2-